ABVC BioPharma Has Received a Cumulative Total of US$566,000 Under ForSeeCon Licensing Agreement Supporting GMP Facility in Hsinchu for Vitargus Production Life Science Investing
PTC to Announce Fourth Fiscal Quarter and Full Year 2025 Results on Wednesday, November 5th, 2025 Life Science Investing
Medtronic initiates U.S. IDE clinical study evaluating Hugo robotic-assisted surgery system for gynecological procedures Medical Device Investing
Vicarious Surgical Announces Pricing of $5.9 Million Registered Direct Offering Medical Device Investing
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025 Biotech Investing
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion Life Science Investing
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025 Biotech Investing
Galectin Therapeutics to Present at the American Association for the Study of Liver Disease Liver Meeting 2025 Life Science Investing
